TY  - GEN
AU  - Polyzos,Aristides
AU  - Kosmas,Christos
AU  - Toufexi,Helen
AU  - Malamos,Nicholas
AU  - Lagadas,Antonios
AU  - Kosmidis,Christos
AU  - Ginopoulos,Panagiotis
AU  - Ziras,Nicholas
AU  - Kandilis,Kostas
AU  - Georgoulias,Vassilis
TI  - Docetaxel in combination with irinotecan (CPT-11) in platinum-resistant paclitaxel-pretreated ovarian cancer
SN  - 0250-7005
PY  - 2005///1013
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Camptothecin
KW  - administration & dosage
KW  - Cisplatin
KW  - pharmacology
KW  - Docetaxel
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Granulocyte Colony-Stimulating Factor
KW  - Humans
KW  - Irinotecan
KW  - Middle Aged
KW  - Ovarian Neoplasms
KW  - drug therapy
KW  - Paclitaxel
KW  - Prospective Studies
KW  - Recombinant Proteins
KW  - Taxoids
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
ER  -